Global Optimism As COVID-19 Vaccines Are Expected to be Released Globally

Financial News Media – Since the global outbreak that triggered the pandemic, scientists around the world have been working on potential treatments and vaccines for the new coronavirus disease known as COVID-19… and they have been making progress at a rapid pace, perhaps the fastest in history.

Several companies are working on antiviral drugs, some of which are already in use against other illnesses, to treat people who have COVID-19, which could provide the fastest track of all. Other companies are working on vaccines that could be used as a preventive measure against the disease. Last week, the FDA granted emergency use authorization for a COVID-19 vaccine created by Pfizer-BioNTech.

An article in Medical News today added: “The United States is the latest country to join Canada and the United Kingdom in approving a COVID-19 vaccine. Creating a vaccine in under 1 year is no small feat. While the coronavirus pandemic made a new normal of mask-wearing and physical distancing, it also spurred global cooperation for vaccine research and distribution.”

Active biotech companies in the Covid-19 developments this week include Pfizer Inc. (NYSE: PFE), BioVaxys Technology Corp. (OTCPK: LMNGF) (CSE: BIOV), Moderna, Inc. (NASDAQ: MRNA), INOVIO (NASDAQ:INO), Sorrento Therapeutics, Inc. (NASDAQ: SRNE).


Share on facebook
Share on twitter
Share on pinterest
Share on linkedin